Cargando…
Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
(1→3)-β-glucan (BDG) testing as an adjunct in the diagnosis of invasive fungal disease (IFD) has been in use for nearly three decades. While BDG has a very high negative predictive value in this setting, diagnostic false positives may occur, limiting specificity and positive predictive value. Althou...
Autor principal: | Finkelman, Malcolm A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824349/ https://www.ncbi.nlm.nih.gov/pubmed/33383818 http://dx.doi.org/10.3390/jof7010014 |
Ejemplares similares
-
Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates
por: Mackay, Cheryl Anne, et al.
Publicado: (2011) -
Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients
por: Levesque, Eric, et al.
Publicado: (2017) -
2036. Plasma (1→3)-β-D-Glucan Levels Correlate with Neurocognitive Functioning in HIV-Infected Adults
por: Hoenigl, Martin, et al.
Publicado: (2018) -
Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016) -
Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan
por: Wong, Jonathan, et al.
Publicado: (2016)